Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Map Pharmaceuticals Inc patents

Recent patent applications related to Map Pharmaceuticals Inc. Map Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Map Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Map Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Map Pharmaceuticals Inc-related inventors

8'-hydroxy-dihydroergotamine compounds and compositions

8′-hydroxy-dihydroergotamine (8′-oh dhe) medicinal compounds, compositions, and dosage forms containing such compositions are provided. Also provided herein are methods of treatment, prevention, or amelioration of diseases, conditions or disorders selected from amyotrophic lateral sclerosis (als), parkinson's disease, stress/anxiety, nausea, emesis, aggression, pain, neuropathic pain, sleeplessness, insomnia, restless leg syndrome and depression using the compounds, compositions, dosage forms and administration techniques disclosed herein.. ... Map Pharmaceuticals Inc

Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile

Pharmaceutical compositions containing dihydroergotamine (dhe) and methods in which dhe is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with dhe are disclosed comprising: dampening the peak plasma concentration (cmax) and slightly delaying the peak such as to avoid activating the dopaminergic and adrenergic receptors, while achieving sufficient active binding to the serotonin receptors to provide relief from migraine symptoms within a timeframe that permits rapid resolution of migraine symptoms. ... Map Pharmaceuticals Inc

Headache pre-emption by dihydroergotamine treatment during headache precursor events

Disclosed are methods that address providing a subject experiencing, or who has experienced, a headache precursor event and administering dihydroergotamine, or a pharmaceutically acceptable salt or complex thereof, to the subject by oral inhalation, in an amount effective to pre-empt a subsequent headache in the subject. Also disclosed are compositions that are related to those methods.. ... Map Pharmaceuticals Inc

Enhanced eductor design

The present invention provides for an enhanced eductor element that significantly increases the amount of pressure generated at the siphon tube without significantly increasing the flow resistance through the eductor. The invention further provides for breath-actuated inhalation devices comprising the enhanced eductor element as an actuation mechanism.. ... Map Pharmaceuticals Inc

Dose counter with lockout mechanism

A medicament dispenser, in particular a metered dose inhaler, which is able to count the number of time the dispenser is activated and then disable the device, which then prevents any additional medicament from being dispensed. Additional embodiments include a medicament dispenser which are adapted to display either the number of activations that have occurred or the number of activations remaining.. ... Map Pharmaceuticals Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Map Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Map Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by